Integra Lifesciences Holdings (IART) Current Deferred Tax Assets (2009 - 2015)

Integra Lifesciences Holdings (IART) has 7 years of Current Deferred Tax Assets data on file, last reported at $46.9 million in Q3 2015.

• For the quarter ending Q3 2015, Current Deferred Tax Assets rose 5.92% year-over-year to $46.9 million; the trailing twelve-month figure through Sep 2015 stood at $46.9 million (up 5.92% YoY), and the FY2014 full-year result was $30.6 million, down 37.13% from the prior year.
• Current Deferred Tax Assets slipped to $46.9 million in Q3 2015, from $58.2 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $64.6 million in Q3 2012 to a low of $30.6 million in Q4 2014.
• A 5-year average of $44.6 million and a median of $40.0 million in 2013 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets surged 77.53% in 2012 and plunged 38.78% in 2013, its largest moves.
• Tracing IART's Current Deferred Tax Assets over 5 years: stood at $36.2 million in 2011, then gained by 8.15% to $39.1 million in 2012, then climbed by 24.34% to $48.6 million in 2013, then sank by 37.13% to $30.6 million in 2014, then jumped by 53.44% to $46.9 million in 2015.
• Business Quant data shows IART's Current Deferred Tax Assets at $46.9 million in Q3 2015, $58.2 million in Q2 2015, and $58.3 million in Q1 2015.